- Home
- TREE vs OPT Comparison
TREE vs OPT Comparison
Compare TREE & OPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TREE
- OPT
- Stock Information
- Founded
- TREE 1996
- OPT 1984
- Country
- TREE United States
- OPT Australia
- Employees
- TREE N/A
- OPT N/A
- Industry
- TREE Finance: Consumer Services
- OPT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- TREE Finance
- OPT Health Care
- Exchange
- TREE Nasdaq
- OPT Nasdaq
- Market Cap
- TREE 712.1M
- OPT 767.9M
- IPO Year
- TREE N/A
- OPT 2020
- Fundamental
- Price
- TREE $44.34
- OPT $3.24
- Analyst Decision
- TREE Buy
- OPT Strong Buy
- Analyst Count
- TREE 8
- OPT 1
- Target Price
- TREE $64.00
- OPT $12.00
- AVG Volume (30 Days)
- TREE 387.2K
- OPT 39.0K
- Earning Date
- TREE 10-31-2024
- OPT 08-30-2024
- Dividend Yield
- TREE N/A
- OPT N/A
- EPS Growth
- TREE N/A
- OPT N/A
- EPS
- TREE N/A
- OPT N/A
- Revenue
- TREE $773,050,000.00
- OPT $261,859.00
- Revenue This Year
- TREE $32.88
- OPT N/A
- Revenue Next Year
- TREE $16.82
- OPT $46,864.64
- P/E Ratio
- TREE N/A
- OPT N/A
- Revenue Growth
- TREE 4.44
- OPT N/A
- 52 Week Low
- TREE $15.69
- OPT $1.79
- 52 Week High
- TREE $62.49
- OPT $5.45
- Technical
- Relative Strength Index (RSI)
- TREE 37.28
- OPT 27.29
- Support Level
- TREE $46.50
- OPT $4.02
- Resistance Level
- TREE $55.00
- OPT $4.18
- Average True Range (ATR)
- TREE 4.37
- OPT 0.22
- MACD
- TREE -0.34
- OPT -0.13
- Stochastic Oscillator
- TREE 5.25
- OPT 6.85
About TREE LendingTree Inc.
LendingTree Inc is a United States-based company that is principally engaged in operating an online loan marketplace. The company provides online tools and resources that can help consumers find loans or other credit-based offerings They need, including mortgage loans, reverse mortgage, home equity, personal loans, auto loans, credit cards, student loans, small business loans, and other related offerings. The company offers consumers direct access to a broad range of lenders. They have three reportable segments which are Home, Consumer, and Insurance. The company generates match fees by matching consumers with lenders, and closing fees from lenders on loans when a transaction is closed. The company operates business solely in the United States.
About OPT Opthea Limited
Opthea Ltd operates in one industry being the medical technology and healthcare. It is focused on developing biological therapeutics for eye diseases. The company is developing a novel biologic therapy, OPT-302, for the treatment of eye diseases. Its products are based on the intellectual property portfolio covering Vascular Endothelial Growth Factors C and D and R3 targets. Opthea's development activities are based on an intellectual property portfolio covering key targets Vascular Endothelial Growth Factors VEGF-C, VEGF-D and VEGF Receptor-3 for the treatment of diseases associated with blood and lymphatic vessel growth, as well as vascular leakage. The company geographically operates Australia and United States.